West Pharmaceutical Services Inc (WST)
362.52
-5.66
(-1.54%)
USD |
NYSE |
Apr 26, 15:05
West Pharmaceutical Services Free Cash Flow: 414.50M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 414.50M |
| September 30, 2023 | 420.00M |
| June 30, 2023 | 396.80M |
| March 31, 2023 | 410.00M |
| December 31, 2022 | 439.40M |
| September 30, 2022 | 387.80M |
| June 30, 2022 | 401.50M |
| March 31, 2022 | 382.00M |
| December 31, 2021 | 330.60M |
| September 30, 2021 | 341.10M |
| June 30, 2021 | 287.40M |
| March 31, 2021 | 307.10M |
| December 31, 2020 | 298.10M |
| September 30, 2020 | 272.10M |
| June 30, 2020 | 277.40M |
| March 31, 2020 | 247.00M |
| December 31, 2019 | 240.80M |
| September 30, 2019 | 215.20M |
| June 30, 2019 | 200.70M |
| March 31, 2019 | 185.70M |
| December 31, 2018 | 183.90M |
| September 30, 2018 | 192.70M |
| June 30, 2018 | 172.30M |
| March 31, 2018 | 166.30M |
| December 31, 2017 | 132.50M |
| Date | Value |
|---|---|
| September 30, 2017 | 104.80M |
| June 30, 2017 | 83.00M |
| March 31, 2017 | 68.40M |
| December 31, 2016 | 49.20M |
| September 30, 2016 | 48.10M |
| June 30, 2016 | 67.50M |
| March 31, 2016 | 77.10M |
| December 31, 2015 | 80.80M |
| September 30, 2015 | 76.30M |
| June 30, 2015 | 72.50M |
| March 31, 2015 | 61.40M |
| December 31, 2014 | 70.80M |
| September 30, 2014 | 78.20M |
| June 30, 2014 | 66.90M |
| March 31, 2014 | 84.60M |
| December 31, 2013 | 64.70M |
| September 30, 2013 | 74.80M |
| June 30, 2013 | 73.40M |
| March 31, 2013 | 31.20M |
| December 31, 2012 | 55.40M |
| September 30, 2012 | 26.20M |
| June 30, 2012 | 19.50M |
| March 31, 2012 | 25.60M |
| December 31, 2011 | 33.90M |
| September 30, 2011 | 50.10M |
Free Cash Flow Range, Past 5 Years
200.70M
Minimum
Jun 2019
439.40M
Maximum
Dec 2022
329.97M
Average
330.60M
Median
Dec 2021
Free Cash Flow Benchmarks
| Becton Dickinson & Co | 2.648B |
| Abbott Laboratories | 5.059B |
| Masimo Corp | 6.40M |
| Merit Medical Systems Inc | 108.45M |
| Insulet Corp | 36.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 239.10M |
| Cash from Investing (Quarterly) | -108.80M |
| Cash from Financing (Quarterly) | -189.50M |
| Free Cash Flow Per Share (Quarterly) | 1.746 |
| Free Cash Flow to Equity (Quarterly) | 130.90M |
| Free Cash Flow to Firm (Quarterly) | 130.40M |
| Free Cash Flow Yield | 1.52% |